Ardelyx, Inc. (ARDX)

NASDAQ: ARDX · Real-Time Price · USD

5.73

-1.01 (-14.99%)

At close: Feb 20, 2026, 4:00 PM EST

5.79

+0.06 (1.03%)

After-hours: Feb 20, 2026, 7:59 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Development and Commercialization of Biopharmaceutical Products				52.16M	10.10M	7.57M	5.28M	2.61M
Development and Commercialization of Biopharmaceutical Products Growth				416.57%	33.36%	43.36%	102.57%	-93.79%
Total				52.16M	10.10M	7.57M	5.28M	2.61M
Total Growth				416.57%	33.36%	43.36%	102.57%	-93.79%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States				15.60M	-	-	-	-
Asia Pacific				36.53M	10.08M	6.77M	-	-
Asia Pacific Growth				262.23%	49.06%	-	-	-
North America				31.00K	13.00K	806.00K	-	-
North America Growth				138.46%	-98.39%	-	-	-
Japan				-	-	-	800.00K	287.00K
Japan Growth				-	-	-	178.75%	-99.04%
Hong Kong				-	-	-	1.50M	-
China				-	-	-	3.00M	-
Canada				-	-	-	-	2.32M
Total				52.16M	10.10M	7.57M	5.30M	2.61M
Total Growth				416.57%	33.36%	42.85%	103.30%	-93.79%

Source: S&P Global Market Intelligence.